IGF2BP1 and ovarian carcinoma: The increased expression of IGF2BP1 is significantly related to the poor prognosis of ovarian cancer, liver cancer, and lung cancer (Huang et al., 2019; Müller et al., 2019; Zhang et al., 2020).